Aarti Pharmalabs Limited (AARTIPHARM.NS)
INR 767.4
(-0.21%)
INR 767.4
(-0.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.12 Billion INR | 10.99% |
| 2022 | 2.81 Billion INR | 366214.11% |
| 2021 | -769.76 Thousand INR | -1574.85% |
| 2020 | -45.96 Thousand INR | 75.39% |
| 2019 | -186.75 Thousand INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 727.9 Million INR | -4.59% |
| 2024 Q1 | 762.93 Million INR | -22.47% |
| 2023 Q4 | 984 Million INR | 25.67% |
| 2023 FY | 3.12 Billion INR | 10.99% |
| 2023 Q3 | 783 Million INR | 10.55% |
| 2023 Q2 | 708.3 Million INR | 3.93% |
| 2023 Q1 | 681.5 Million INR | 3.81% |
| 2022 Q3 | 693.99 Million INR | -5.19% |
| 2022 FY | 2.81 Billion INR | 366214.11% |
| 2022 Q2 | 732 Million INR | 11.5% |
| 2022 Q4 | 656.49 Million INR | -5.4% |
| 2022 Q1 | 656.49 Million INR | -20.35% |
| 2021 Q4 | 824.19 Million INR | -0.0% |
| 2021 Q2 | -77.51 Thousand INR | 0.0% |
| 2021 Q3 | 824.21 Million INR | 1063355.65% |
| 2021 FY | -769.76 Thousand INR | -1574.85% |
| 2021 Q1 | -77.51 Thousand INR | 0.0% |
| 2020 FY | -45.96 Thousand INR | 75.39% |
| 2019 FY | -186.75 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eris Lifesciences Limited | 5.18 Billion INR | 39.632% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -110401.882% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -403.7% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 45.675% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 30.081% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -1216.209% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -154.112% |
| Brooks Laboratories Limited | -72.25 Million INR | 4429.452% |
| Ipca Laboratories Limited | 29.59 Billion INR | 89.431% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -1361.463% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 39.716% |
| Laurus Labs Limited | 3.94 Billion INR | 20.779% |
| Medico Remedies Limited | 277.11 Million INR | -1028.803% |
| Neuland Laboratories Limited | 5.31 Billion INR | 41.18% |
| Shilpa Medicare Limited | 3.76 Billion INR | 16.84% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 181.189% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 32.11% |
| Vaishali Pharma Limited | 6.29 Million INR | -49599.968% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Windlas Biotech Limited | 1.29 Billion INR | -140.83% |
| ZIM Laboratories Limited | 1.09 Billion INR | -184.863% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 58.522% |
| Alkem Laboratories Limited | 19.46 Billion INR | 83.927% |
| Divi's Laboratories Limited | 18.31 Billion INR | 82.916% |
| Bal Pharma Limited | 214.56 Million INR | -1357.86% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 97.007% |
| FDC Limited | 3.03 Billion INR | -3.111% |
| Granules India Limited | 6.52 Billion INR | 52.083% |
| Hester Biosciences Limited | 364.77 Million INR | -757.558% |
| Ind-Swift Limited | 1.22 Billion INR | -155.156% |
| Morepen Laboratories Limited | 4.17 Billion INR | 25.054% |
| Orchid Pharma Limited | 2.36 Billion INR | -32.487% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Sigachi Industries Limited | 1.47 Billion INR | -112.235% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 93.109% |
| Aarti Drugs Limited | 7.14 Billion INR | 56.242% |
| Ajanta Pharma Limited | 19.67 Billion INR | 84.103% |
| Alembic Limited | 767.77 Million INR | -307.429% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -15043.861% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 56.706% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 95.381% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 65.163% |
| Hikal Limited | 1.49 Billion INR | -109.351% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -55.703% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -1403.54% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -11292.367% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 19.598% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -467.11% |
| RPG Life Sciences Limited | 2.29 Billion INR | -36.462% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Venus Remedies Limited | 534.65 Million INR | -485.076% |
| Wanbury Limited | 1.7 Billion INR | -83.23% |
| Wockhardt Limited | 140 Million INR | -2134.369% |
| Innova Captab Limited | 2.53 Billion INR | -23.475% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -12.28% |
| Themis Medicare Limited | 1.3 Billion INR | -140.051% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 36.706% |
| Mankind Pharma Limited | 40.86 Billion INR | 92.346% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 51.893% |
| Sakar Healthcare Limited | 495.5 Million INR | -531.297% |
| Albert David Limited | 1.33 Billion INR | -134.411% |
| Lupin Limited | 27.75 Billion INR | 88.731% |
| Gufic Biosciences Limited | 2.89 Billion INR | -8.097% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 97.001% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -64.091% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1155.006% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 87.653% |
| NATCO Pharma Limited | 25.96 Billion INR | 87.951% |
| Suven Life Sciences Limited | -1.22 Billion INR | 355.185% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 40.141% |
| Indoco Remedies Limited | 1.52 Billion INR | -105.203% |
| Alpa Laboratories Limited | 61.51 Million INR | -4985.127% |
| Lasa Supergenerics Limited | -458 Million INR | 782.987% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 176.017% |